CD274 and hepatocellular carcinoma: Therefore, in order for PD-1 or PDL-1 inhibitors to be effective in boosting the T-cell immune response against HCC cells, it is necessary to combine them with other means to pursue the goal of amplifying the immunotherapeutic effect, for example, by evoking immunogenic cell death (ICD) to achieve the modification of the immune microenvironment.